Breast conservation: Evolution of surgical strategies

Breast Journal

Volumn 12, Issue SUPPL. 2, 2006, Pages

  Fitzal, Florian ^a   Gnant, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Breast cancer; Breast surgery; Central resection

Indexed keywords

BIOLOGICAL MARKER;

BREAST CANCER; BREAST RECONSTRUCTION; BREAST SURGERY; FROZEN SECTION; HUMAN; PARTIAL MASTECTOMY; REVIEW; SEGMENTAL MASTECTOMY; SOCIAL PSYCHOLOGY; SURGICAL TECHNIQUE;

BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL;

EID: 33748357327     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00330.x     Document Type: Review

References (56)

1. Keynes G. Conservative treatment of the breast. Br Med J 1937;2:643-47.
2. McKinnon WE. Control of cancer mortality. Lancet 1954;266:251-54.
3. Park WW, Lee JC. The absolute curability of cancer of the breast. Surg Gynecol Obstet 1951;93:129-52.
4. Atkins H, Hayward JL, Klugman DJ, Wayte AB. Treatment of early breast cancer: a report after ten years of a clinical trial. Br Med J 1972;2:423-29.
5. Mustakallio S. Conservative treatment of breast carcinoma - review of 25 years follow up. Clin Radiol 1972;23:110-16.
6. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32.
7. Arriagada R, Le MG, Guinebretiere JM, Dunant A, Rochard F, Tursz T. Late local recurrences in a randomized trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 2003;14:1617-22.
8. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
9. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003;98:697-702.
10. van Dongon JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000;92:1143-50.
11. Blichert-Toft M, Rose C, Anderson JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992;11:19-25.
12. Jatoi Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol 2005;28:289-94.
13. van der Hage JA, Putter H, Bonnema J, Bartelink H, Theraasse P, van de Velde CJ. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis. Eur J Cancer 2003;39:2192-99.
14. Early stage breast cancer: consensus statement. NIH consensus development conference, June 18-21, 1990. Cancer Treat Res 1992;60:383-93.
15. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights. International Consensus Panel on the Treatment of Primary Breast Cancer. J Clin Oncol 2001;19:3817-27.
16. Scarth H, Cantin J, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update). CMAJ 2002;167:154-55.
17. Horst KC, Smitt MC, Goffinet DR, Carlson RW. Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 2005;5:425-38.
18. DiBiase SJ, Komarnicky LT, Schwartz GF, Xie Y, Mansfield CM. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 1998;82:2212-20.
19. Smitt MC, Nowels K, Carlson RW, Jeffery SS. Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys 2003;57:979-85.
20. Jakesz R, Samonigg H, Gnant M, et al. Significant increases in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group. Ann Surg 2003;237:556-64.
21. Khanna MM, Mark RJ, Silverstein MJ, Juillard G, Lewinsky B, Giuliano AE. Breast conservation management of breast tumors 4 cm or larger. Arch Surg 1992;127:1038-41; discussion 1041-43.
22. Asgeirsson KS, McCulley SJ, Pinder SE, Macmillan RD. Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy. Eur J Cancer 2003;39:2462-69.
23. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971-77.
24. White RR, Halperin TJ, Olson JA Jr, Soo MS, Bently RC, Seigler HF. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities. Ann Surg 2001;233:769-77.
25. Cox CE, Reintgen DS, Nicosia SV, Ku NN, Baekey P, Carey LC. Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology. Ann Surg Oncol 1995;2:201-6.
26. King TA, Cederbom GJ, Champaign JL, et al. A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning. Am J Surg 1998;176:497-501.
27. Spivack B, Khanna MM, Tafra L, Juillard G, Giuliano AE. Margin status and local recurrence after breast-conserving surgery. Arch Surg 1994;129:952-56; discussion 956-57.
28. Wazer DE, DiPetrillo T, Schmidt-Ullrich R, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1992;10:356-63.
29. Fitzal F, Sporn E, Riedl O, et al. Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Res Treat 2006;97:9-15.
30. Fechner RE. Frozen section examination of breast biopsies. Practice parameter. Am J Clin Pathol 1995;103:6-7.
31. Sauter ER, Hoffman JP, Ottery FD, et al. Is frozen section analysis of reexcision lumpectomy margins worthwhile? Margin analysis in breast reexcisions. An evaluation of frozen section biopsy in 4434 cases. The reliability of frozen-section diagnosis in various breast lesions: a study based on 3451 biopsies. Cancer 1994;73:2607-12.
32. McBain CA, Young EA, Swindell R, Magee B, Stewart AL. Local recurrence of breast cancer following surgery and radiotherapy: incidence and outcome. Clin Oncol (R Coll Radiol) 2003;15:25-31.
33. Abner AL, Recht A, Eberlein T, et al. Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 1993;11:44-48.
34. Komoike Y, Motomura K, Inaji H, Kasugai T, Koyama H. Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery. Preliminary results. Oncology 2003;64:1-6.
35. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000;92:1143-50.
36. Pendlebury SC, Ivanov O, Renwick S, Stevens GN. Long-term review of a breast conservation series and patterns of care over 18 years. Aust N Z J Surg 2003;73:577-83.
37. Komoike Y, Akiyama F, Iino Y, et al. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer 2005;12:104-11.
38. Huang E, Buchholz TA, Meric F, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 2002;95:2059-67.
39. Jakesz R, Hausmaninger H, Kubista E, et al. Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer - Austrian Breast and Colorectal Study Group Trial 5. J Clin Oncol 2002;20:4621-27.
40. Morrow M. Limiting breast surgery to the proper minimum. Breast 2005;14:523-26.
41. Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996;78:1921-28.
42. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990;8:113-18.
43. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Ductal carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50:1309-14.
44. Faverly DR, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994;11:193-98.
45. van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary operable breast cancer. results from the European Organization for Research and Treatment of Cancer Trial 10902. J Clin Oncol 2001;19:4224-37.
46. Turner BC, Gumbs AA, Carbone CJ, Carter D, Glazer PM, Haffty BG. p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy. Cancer 2000;88:1091-98.
47. Kim R, Nishimoto N, Osaki A, et al. An analysis of relapsed breast cancer in patients previously treated with breast conserving surgery. Breast Cancer 2001;8:146-52.
48. Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer 2000;36:1938-43.
49. Figueiredo MI, Cullen J, Hwang YT, Rowland JH, Mandelblatt JS. Breast cancer treatment in older women: does getting what you want improve your long-term body image and mental health? J Clin Oncol 2004;22:4002-9.
50. Cochrane RA, Valasiadou P, Wilson AR, Al-Ghazal SK, Macmillan RD. Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br J Surg 2003;90:1505-9.
51. Al-Ghazal SK, Fallowfield L, Blamey RW. Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol 1999;25:571-73.
52. Al-Ghazal SK, Fallowfield L, Blamey RW. Patient evaluation of cosmetic outcome after conserving surgery for treatment of primary breast cancer. Eur J Surg Oncol 1999;25:344-46.
53. Hoeller U, Kuhlmey A, Barjrovic A, et al. Cosmesis from the patient's and the doctor's view. Int J Radiat Oncol Biol Phys 2003;57:345-54.
54. Pezner RD, Patterson MP, Hill LR, Vora NL, Desai KR, Lipsett JA. Breast retraction assessment. Multiple variable analysis of factors responsible for cosmetic retraction in patients treated conservatively for stage I or II breast carcinoma. Acta Radiol Oncol 1985;24:327-30.
55. Pezner RD, Patterson MP, Hill LR, et al. Breast retraction assessment. an objective evaluation of cosmetic results of patients treated conservatively for breast cancer. Int J Radiat Oncol Biol Phys 1985;11:575-78.
56. Rose MA, Olivotto I, Cady B, et al. Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg 1989;124:153-57.